Skip to main content

ACR 2022 Tweet by Patricia Harkins

View on
Yr in review #ACR22 @RheumNow
🌟GLORIA 2 yr data:
👉Pred 5mg OD vs PBO >65y/o RA

✅⬇️ disease activity (DAS28 -0.38)

✅⬇️ joint damage (sharp/van der heijde -1.7)

❌ 24% ⬆️ a/e

“Weigh success in benefit and failure in harm 2 individualise use of low dose pred in RA >65y/o”
×